£107.66

Springer Next Generation Antibody Drug Conjugates (ADCs) and Immunotoxins (Milestones in Drug Therapy)

Price data checked 1 day ago

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

About as cheap as it gets. The only time it was cheaper was 3 months ago.

£108 today · all-time low £105 (Feb 2026) · usually £111

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 90 days • 90 data points

Historical
Generating forecast...
£113.63 £104.06 £106.15 £108.24 £110.32 £112.41 £114.50 18 February 2026 12 March 2026 03 April 2026 25 April 2026 18 May 2026

Price Distribution

Price distribution over 90 days • 5 price levels

Days at Price
Current Price
20 days 21 days · current 17 days 15 days 17 days 0 5 11 16 21 £105 £108 £109 £111 £114 Days at Price

Price Analysis

Most common price: £108 (21 days, 23.3%)

Price range: £105 - £114

Price levels: 5 different prices over 90 days

Description

This book describes the newest developments in antibody drug conjugates and immunotoxins, paving their way to clinical application. Lessons learned from the current state of the art are used to further improve our understanding of their mechanisms of action and off target activities. The book introduces scientists to all of the prerequisites that must be properly addressed, including identification of the right target, specific traits of target binding antibodies, proper selection of the toxic payload, internalization induced by binding, and next generation conjugation and linker technologies. These knowledge-based, revolutionary new drug principles will form the cornerstone of the future standard of care and will lead to major advances in application, as well as improved quality of life and patient survival rates. This book will be of interest to biotech companies and researchers working in the fields of immunology, pharmacology, and oncology.

Product Specifications

Barcode

No barcode data available

Similar Products You Might Like

Advances in Tumor Immunology and Immunotherapy (Current Cancer Research)
84% match

Advances in Tumor Immunology and Immunotherapy (Current Cancer Research)

Springer

£111.48 18 May 2026
General Principles of Tumor Immunotherapy: Basic and Clinical Applications of Tumor Immunology
83% match

General Principles of Tumor Immunotherapy: Basic and Clinical Applications of Tumor Immunology

Springer

£147.83 11 May 2026
Cancer Immunotherapy: Paradigms, Practice and Promise
82% match

Cancer Immunotherapy: Paradigms, Practice and Promise

Springer

£108.92 18 May 2026
Molecular Imaging for Integrated Medical Therapy and Drug Development
82% match

Molecular Imaging for Integrated Medical Therapy and Drug Development

Springer

£113.93 18 May 2026
Pharmacology of Immunotherapeutic Drugs
82% match

Pharmacology of Immunotherapeutic Drugs

Springer

£74.05 18 May 2026
Immunogenicity of Biopharmaceuticals: VIII (Biotechnology: Pharmaceutical Aspects, VIII)
82% match

Immunogenicity of Biopharmaceuticals: VIII (Biotechnology: Pharmaceutical Aspects, VIII)

Springer

£107.98 18 May 2026
Integrin Targeting Systems for Tumor Diagnosis and Therapy (Methods in Pharmacology and Toxicology)
82% match

Integrin Targeting Systems for Tumor Diagnosis and Therapy (Methods in Pharmacology and Toxicology)

Humana

£69.34 18 May 2026
Targeted Radionuclide Tumor Therapy: Biological Aspects
82% match

Targeted Radionuclide Tumor Therapy: Biological Aspects

Springer

£123.38 11 May 2026
Antibodies: Volume 1: Production and Purification
82% match

Antibodies: Volume 1: Production and Purification

Springer

£108.86 18 May 2026
Enzyme-Prodrug Strategies for Cancer Therapy
81% match

Enzyme-Prodrug Strategies for Cancer Therapy

Springer

£148.84 18 May 2026
Gene Therapy of Autoimmune Disease (Medical Intelligence Unit)
81% match

Gene Therapy of Autoimmune Disease (Medical Intelligence Unit)

Springer

£106.16 18 May 2026
Optical Imaging of Cancer: Clinical Applications
81% match

Optical Imaging of Cancer: Clinical Applications

Springer

£107.98 19 May 2026
Development of Novel Vaccines: Skills, Knowledge and Translational Technologies
81% match

Development of Novel Vaccines: Skills, Knowledge and Translational Technologies

Springer

£107.78 18 May 2026
Infectious Complications in Biologic and Targeted Therapies
81% match

Infectious Complications in Biologic and Targeted Therapies

Springer

£80.64 14 May 2026
Antibody Engineering: Methods and Protocols, Second Edition: 907 (Methods in Molecular Biology, 907)
80% match

Antibody Engineering: Methods and Protocols, Second Edition: 907 (Methods in Molecular Biology, 907)

Humana

£126.48 18 May 2026
Drug Targeting Complexity: Tissue-Specific Regulation and Molecular Paradigms in Cancer Therapy
80% match

Drug Targeting Complexity: Tissue-Specific Regulation and Molecular Paradigms in Cancer Therapy

Academic Press

£157.99 11 May 2026
New Concepts of Antiviral Therapy
80% match

New Concepts of Antiviral Therapy

Springer

£77.33 11 May 2026
The Challenge of CMC Regulatory Compliance for Biopharmaceuticals
80% match

The Challenge of CMC Regulatory Compliance for Biopharmaceuticals

Springer

£111.72 18 May 2026
Cancer Drug Discovery: Science and History
80% match

Cancer Drug Discovery: Science and History

Springer

£109.19 18 May 2026
NK Cells in Cancer Immunotherapy: Successes and Challenges (Volume 4) (Breaking Tolerance to Anti-Cancer Cell-Mediated Immunotherapy, Volume 4)
80% match

NK Cells in Cancer Immunotherapy: Successes and Challenges (Volume 4) (Breaking Tolerance to Anti-Cancer Cell-Mediated Immunotherapy, Volume 4)

Academic Press

£111.99 17 May 2026
Nutraceuticals and Cancer
80% match

Nutraceuticals and Cancer

Springer

£113.76 18 May 2026
Biopharmaceutical Drug Design and Development
80% match

Biopharmaceutical Drug Design and Development

Humana

£108.92 11 May 2026
80% match

Molecular and Cellular Biology Approaches and Applications in Modern Drug Discovery

Academic Press

£157.99 11 May 2026
Pathobiology of Cancer Regimen-Related Toxicities
80% match

Pathobiology of Cancer Regimen-Related Toxicities

Springer

£107.98 18 May 2026